In the realm of skincare, blue copper peptide (GHK-Cu) has long been hailed as a star ingredient in anti-aging formulations for its exceptional efficacy in promoting collagen production, providing antioxidant benefits, and accelerating wound healing. However, recent research indicates that GHK-Cu's potential extends far beyond this-it is transcending the singular domain of skincare to venture into entirely new frontiers such as neuroprotection, metabolic regulation, and even cross-species applications. This groundbreaking crossover not only charts new directions for medical research but may fundamentally reshape humanity's understanding of "anti-aging."
Hot sale
Certificate
|
|
||
| Certificate of Analysis | ||
| Compound name | GHK-Cu | |
| CAS No. | 49557-75-7 | |
| Quantity | 30g | |
| Package | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 20250528015 | |
| MFG | May 28th 2025 | |
| EXP | May 28th 2028 | |
| Structure |
|
|
| Test standard | GB/T24768-2009 Industry. Standard | |
| Item | Enterprise standard | |
| Appearance | Light blue to blue solid | |
| Water content | ≤5.0% | |
| Heavy Metals | Pb≤0.5ppm | |
| As≤0.5ppm | ||
| Hg≤0.5ppm | ||
| Cd≤0.5ppm | ||
| Purity (HPLC) | ≥99.2% | |
| Single impurity | <0.5% | |
| Total microbial count | ≤500cfu/g | |
| E. Coli | ≤2MPN/g | |
| Salmonella | N.D. | |
| Ethanol (by GC) | ≤3000ppm | |
| Storage | Store in a sealed, dark and dry place at 2-8 degrees | |
|
|
||
|
|
||
| Chemical Formula: | C14H24N6O4 | |
| Exact Mass: | 340.19 | |
| Molecular Weight: | 340.38 | |
| m/z: | 340.19 (100.0%), 341.19 (15.1%), 341.18 (2.2%), 342.19 (1.1%) | |
| Elemental Analysis: | C, 49.40; H, 7.11; N, 24.69; O, 18.80 | |
Skin Repair
The "Molecular Switch" for Collagen Synthesis
The regulatory mechanism of GHK-Cu on collagen synthesis fundamentally involves the dual action of copper ions and the tripeptide structure. Copper ions, as cofactors for lysyl oxidase, directly participate in the cross-linking and solidification of collagen fibers. Meanwhile, the GHK tripeptide activates the TGF-β/Smad signaling pathway to upregulate the expression of type I procollagen genes. Clinical data indicates that a 0.5% GHK-Cu solution increases dermal collagen density by 23% within 28 days. This effect stems from its promotion of fibroblast proliferation-experiments demonstrate GHK-Cu enhances fibroblast migration rates by 40% while simultaneously inhibiting MMP-1 (matrix metalloproteinase) activity, establishing a dynamic "synthesis-degradation" equilibrium.
Molecular Reconstruction of Barrier Function
In sensitive skin repair, GHK-Cu rebuilds the skin's physical barrier by regulating filaggrin synthesis. This mechanism involves GHK tripeptide binding to integrin β1 on keratinocyte membranes, activating the PI3K/Akt pathway, and promoting the expression of tight junction proteins (Claudin-1, Occludin). In post-laser repair, the GHK-Cu/hyaluronic acid nanocomplex reduces transepidermal water loss (TEWL) by 18%, with effects visible within 24 hours post-procedure-significantly outperforming traditional growth factor products.
Dual-Action Antioxidant Defense
GHK-Cu's antioxidant mechanism exhibits spatiotemporal synergy: copper ions directly quench superoxide anions via redox reactions (Cu²⁺↔Cu⁺), while the GHK tripeptide activates the Nrf2/ARE pathway to upregulate antioxidant enzymes like SOD and CAT. In a UV exposure model, GHK-Cu reduced malondialdehyde (MDA) levels-a lipid peroxidation product-by 60% while maintaining intracellular glutathione (GSH) levels above 85% of normal ranges. This "immediate scavenging + sustained defense" approach achieves antioxidant efficacy five times greater than vitamin C.
Neuroprotection
Novel Intervention Targets for Alzheimer's Disease: In Aβ-induced neurotoxicity models, GHK-Cu exerts protective effects through dual mechanisms. First, copper ions bind to histidine residues in the Aβ42 peptide, inhibiting oligomer formation and reducing fibrillation by 60%. Second, the GHK tripeptide activates the Wnt/β-catenin pathway, promoting hippocampal neural stem cell proliferation and increasing BDNF expression by 35%. Experiments demonstrate that GHK-Cu elevates synaptic plasticity markers SYN and PSD-95 expression by 35% in AD model mice, while improving spatial memory capacity by 40%. Regarding drug delivery, the liposomal formulation of GHK-Cu (particle size 120 nm, surface-modified with transferrin) penetrates the blood-brain barrier, achieving brain tissue concentrations 3.2 times higher than plasma levels. This targeted delivery system demonstrated significant therapeutic effects in AD model mice: after 8 weeks of continuous administration, hippocampal Aβ plaque levels decreased by 42%, and neuronal survival rates increased by 67%.
Restoration of Motor Function in Parkinson's Disease: In MPTP-induced PD macaque models, GHK-Cu improved motor function by modulating the nigrostriatal pathway. Its mechanism involves three aspects: First, it inhibits abnormal aggregation of α-synuclein (α-syn), reducing Lewy body counts by 58%; Second, it activated the PI3K/Akt/mTOR pathway to promote dopaminergic neuron survival. Third, it upregulated GDNF expression to enhance neuroprotection. Behavioral tests revealed that after 12 weeks of continuous administration, macaques exhibited a 58% improvement in gait stability and a 41% to 79% increase in grip success rate.
Protection against Cerebral Ischemia-Reperfusion Injury: In a rat MCAO model, GHK-Cu pretreatment (0.2 mg/kg, tail vein injection, 24 hours pre-surgery) reduced infarct volume by 53% and decreased neurological deficit scores by 62%. Its protective mechanism involves inhibiting mitochondrial permeability transition pore (mPTP) opening, increasing mitochondrial membrane potential retention from 41% to 78% while reducing cytochrome c release by 64%. Further studies revealed that GHK-Cu enhances cellular tolerance to oxidative stress by activating the Nrf2/ARE pathway, upregulating HO-1 and NQO1 expression.
Molecular Mechanisms of Neural Regeneration and Repair:
GHK-Cu's role in neural regeneration is closely linked to its regulation of stem cell behavior. In vitro experiments demonstrated that 0.1μM GHK-Cu increased neural stem cell proliferation rates by 2.3-fold while promoting differentiation into neurons and oligodendrocytes. This effect stems from GHK-Cu's inhibition of the Notch signaling pathway and activation of the BMP signaling pathway, thereby disrupting stem cell quiescence and initiating the regeneration program.
In peripheral nerve injury repair, the neurotrophic conduit formed by GHK-Cu and chitosan demonstrates significant advantages. In a rat sciatic nerve defect model, this conduit enabled regenerated axon counts reaching 91% of the autologous transplantation group, with motor function recovery scores improving to 87%. The mechanism involves GHK-Cu promoting Schwann cell migration and inducing myelin formation, increasing myelin thickness by 40%.
From Basic Research to Biomaterials Innovation
Controlled-Release Systems in Neural Conduits
The newly developed GHK-Cu/PLGA neural conduit employs 3D printing technology to construct a scaffold structure with gradient porosity. In vitro release testing demonstrated a burst release of 28% within the first 72 hours, followed by sustained release of 62% over the subsequent 14 days. Following implantation in a rat sciatic nerve defect model, regenerated axon counts reached 91% of the autologous transplant group at 8 weeks, with motor function recovery scores improving to 87%.
Synergistic Delivery in Hydrogels
A GHK-Cu/BDNF composite hydrogel based on hyaluronic acid-chitosan forms nanocomposites via electrostatic interactions. This system simultaneously released GHK-Cu (82% within 14 days) and BDNF (76% within 14 days) in vitro, enhancing Schwann cell migration rate by 3.2-fold and myelin formation rate by 2.8-fold. In a diabetic rat peripheral nerve injury model, the hydrogel restored nerve conduction velocity to 84% of normal levels.
Biofunctionalization of Antioxidant Coatings
GHK-Cu demonstrates unique advantages in functionalizing biomaterial surfaces. For instance, covalently bonding GHK-Cu to titanium alloy implant surfaces increased osteoblast adhesion by 2.1-fold and accelerated osseointegration by 40%. This mechanism involves GHK-Cu's upregulation of integrin β1 expression and activation of the MAPK signaling pathway, thereby promoting extracellular matrix deposition.
Research Progress on Cross-Boundary Applications of GHK-Cu
Studies on the Connection Between Skin and Brain Health
In recent years, with deepening research on the "brain-skin axis," scientists have gradually discovered a close connection between skin health and brain health. Psychological factors such as stress and emotional fluctuations can influence skin health through complex physiological mechanisms, and vice versa. GHK-Cu, as an active substance capable of simultaneously acting on both skin and brain, has emerged as a crucial tool for studying the "brain-skin axis." Research indicates that GHK-Cu not only improves skin health but also promotes brain health by regulating neurotransmitter synthesis and release, enhancing cognitive function, and other mechanisms.
Preclinical Studies
Preclinical research further validates GHK-Cu's cross-domain application potential. Animal studies demonstrate that GHK-Cu accelerates skin wound healing and nerve regeneration while enhancing cognitive function. For instance, in diabetic rat models of ischemic wounds, GHK-Cu significantly promotes wound healing, reduces TNF-alpha levels, and stimulates collagen synthesis. Regarding cognitive enhancement, animal studies demonstrate that GHK-Cu promotes the growth and differentiation of hippocampal neurons, enhances synaptic plasticity, and consequently improves memory and learning capacity.
Clinical Trials
Although clinical trials on GHK-Cu's application in the brain remain relatively limited, preliminary research has shown its potential. For instance, a small-scale clinical trial in elderly individuals found that GHK-Cu supplementation significantly improved cognitive function metrics such as memory and attention. Additionally, case studies have reported positive effects of GHK-Cu in alleviating symptoms of neurodegenerative diseases. However, due to factors like limited sample sizes and variations in study designs, these findings require further validation.
Frequently Asked Questions
What does GHK-Cu peptide do?
+
-
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring peptide that promotes skin rejuvenation, tissue repair, and hair growth by stimulating collagen/elastin production, enhancing wound healing, reducing inflammation, and acting as an antioxidant, helping to reverse signs of aging like wrinkles, loss of elasticity, and thinning hair, and is used in cosmetics and therapies for skin health and hair support.
How long does it take for GHK-Cu to work?
+
-
GHK-Cu (Copper Peptide) results vary, but expect subtle improvements (hydration, texture) in 2-4 weeks, with more significant changes like reduced fine lines, firmness, and elasticity emerging in 1-3 months, and fuller benefits appearing after 3-6 months of consistent use, especially for skin rejuvenation and hair growth. Consistency and patience are key, as it works with natural processes rather than overnight.
Can GHK-Cu regrow hair?
+
-
Yes, GHK-Cu (copper peptide) shows strong potential for supporting hair regrowth and improving scalp health by stimulating follicles, increasing blood flow, boosting collagen, and reducing inflammation, making hair appear thicker, but it's best as a supportive treatment with other methods, requiring consistent use for months to see results like reduced shedding and fuller hair. While lab studies are promising, human clinical evidence is still developing, so it's not a standalone cure but an exciting addition to hair care routines, often used with minoxidil or microneedling for enhanced effects.
Hot Tags: Best Ghk-Cu Peptide Injection, China Best Ghk-Cu Peptide Injection manufacturers, suppliers, Botulinum Toxin Injection 100iu, Nad Capsule, Nad Peptide Injection, Nad Tablet, BPC 157 Peptide Cream, BPC 157 Peptide Capsules
